Elucidating the Cell-Specific Roles of ABCA7

Principal Investigator
Holly Cukier, PhD
University of Miami, Miller School of Medicine
Coral Gables, FL, USA
About the Research Project
Program
Award Type
Standard
Award Amount
$300,000
Active Dates
July 01, 2018 - June 30, 2021
Grant ID
A2018197S
Co-Principal Investigator(s)
Derek Dykxhoorn, Miller School of Medicine of the University of Miami
Goals
Alzheimer’s disease (AD) occurs more frequently in diverse populations (ie: African Americans and Hispanics) than in white populations. This proposal seeks to investigate the role of a gene shown to be a risk factor for AD, ABCA7, and the consequence of a mutation that was first identified in African Americans. Stem cell lines have been generated from African Americans with this deletion and both neurons and cells involved in immunity, microglia, will be created. Using these two cell types, we will investigate how this deletion may affect the normal way neurons and microglia develop, and how that may lead to AD.
Summary
We hope to better understand the role that a deletion that we recently identified in ABCA7, a gene implicated in Alzheimer’s disease (AD) across populations, plays in the development of AD. The deletion was first identified in African Americans (AA), who comprise an underserved population, and the deletion appears to be of African origin. Since ABCA7 is expressed in a variety of cell types, we will we will generate both neurons and microglia, support cells to the neurons, from stem cell lines of AD patients with the ABCA7 deletion, as well as control stem cells lacking the deletion. Both the neurons and microglia will be functionally characterized for cellular and morphological features, as well as for AD-specific features. We will then combine the neurons and microglia (control neurons with AD microglia and vice versa) to determine whether one cell type contributes more to the AD specific phenotypes, or if there is a synergistic effect between the two cell types. We aim to determine if this deletion is sufficient to induce AD pathogenesis, as well as gain a greater insight into ABCA7, a gene implicated in AD across populations. The ultimate goal is to determine whether ABCA7 is a suitable target for the development of novel AD therapeutics.
Grants
Related Grants
Alzheimer's Disease Research
Regulatory Mechanisms Underlying Endosomal Targeting of SORL1
Active Dates
January 01, 2025 - December 31, 2026
Principal Investigator
Olav Andersen, PhD
Regulatory Mechanisms Underlying Endosomal Targeting of SORL1
Active Dates
January 01, 2025 - December 31, 2026

Principal Investigator
Olav Andersen, PhD
Alzheimer's Disease Research
The Role of DYRK1A in Altered Microglia Biology in a Cellular Model of Alzheimer’s Disease in Down Syndrome
Active Dates
January 01, 2025 - December 31, 2027
Principal Investigator
Frances Wiseman, PhD
The Role of DYRK1A in Altered Microglia Biology in a Cellular Model of Alzheimer’s Disease in Down Syndrome
Active Dates
January 01, 2025 - December 31, 2027

Principal Investigator
Frances Wiseman, PhD
Alzheimer's Disease Research
Synergistic Effects of Biological Sex and Sleep Loss in an AD Mouse Model
Active Dates
January 01, 2025 - December 31, 2026
Principal Investigator
Mallar Chakravarty, PhD
Synergistic Effects of Biological Sex and Sleep Loss in an AD Mouse Model
Active Dates
January 01, 2025 - December 31, 2026
Principal Investigator
Mallar Chakravarty, PhD